tradingkey.logo

Venus Concept Inc

VERO
查看详细走势图
1.760USD
-0.020-1.12%
收盘 12/24, 13:00美东报价延迟15分钟
3.27M总市值
亏损市盈率 TTM

Venus Concept Inc

1.760
-0.020-1.12%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.12%

5天

-3.30%

1月

-3.83%

6月

-20.00%

今年开始到现在

-57.50%

1年

-55.56%

查看详细走势图

TradingKey Venus Concept Inc股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Venus Concept Inc当前公司基本面数据相对稳定,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名138/206位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价0.00。中期看,股价处于下降通道。近一个月,市场表现较差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

Venus Concept Inc评分

相关信息

行业排名
138 / 206
全市场排名
357 / 4562
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 2 位分析师
持有
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Venus Concept Inc亮点

亮点风险
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
业绩增长期
公司处于发展阶段,最新年度总收入64.83M美元
估值高估
公司最新PE估值-0.04,处于3年历史高位
机构加仓
最新机构持股256.25K股,环比增加19.61%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值2.03K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.97

Venus Concept Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Venus Concept Inc简介

Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
公司代码VERO
公司Venus Concept Inc
CEODe Silva (Rajiv D)
网址https://www.venusconcept.com/en-uk/

常见问题

Venus Concept Inc(VERO)的当前股价是多少?

Venus Concept Inc(VERO)的当前股价是 1.760。

Venus Concept Inc的股票代码是什么?

Venus Concept Inc的股票代码是VERO。

Venus Concept Inc股票的52周最高点是多少?

Venus Concept Inc股票的52周最高点是14.500。

Venus Concept Inc股票的52周最低点是多少?

Venus Concept Inc股票的52周最低点是1.650。

Venus Concept Inc的市值是多少?

Venus Concept Inc的市值是3.27M。

Venus Concept Inc的净利润是多少?

Venus Concept Inc的净利润为-47.00M。

现在Venus Concept Inc(VERO)的股票是买入、持有还是卖出?

根据分析师评级,Venus Concept Inc(VERO)的总体评级为持有,目标价格为--。

Venus Concept Inc(VERO)股票的每股收益(EPS TTM)是多少

Venus Concept Inc(VERO)股票的每股收益(EPS TTM)是-40.285。
KeyAI